Log on/register
BioMed Central home | Journals A-Z | Feedback | Support | My details
articles

 April 2008 - Browse articles 
Research    
The effect of radio-adaptive doses on HT29 and GM637 cells
Silke B Schwarz, Pamela M Schaffer, Ulrike Kulka, Birgit Ertl-Wagner, Roswitha Hell, Moshe Schaffer
Radiation Oncology 2008, 3:12 (23 April 2008)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]

Research    
Conventionally-fractionated image-guided intensity modulated radiotherapy (IG-IMRT): a safe and effective treatment for cancer spinal metastasis
Youling Gong, Jin Wang, Sen Bai, Xiaoqin Jiang, Feng Xu
Radiation Oncology 2008, 3:11 (22 April 2008)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

Study protocol    
Study protocol of the German "Registry for the Detection of Late Sequelae after Radiotherapy in Childhood and Adolescence" (RiSK)
Tobias Bolling, Andreas Schuck, Hildegard Pape, Christian Rube, Barbara Pollinger, Beate Timmermann, Rolf D Kortmann, Karin Dieckmann, Normann Willich
Radiation Oncology 2008, 3:10 (21 April 2008)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]

Research    
High-dose-rate brachytherapy for soft tissue sarcoma in children: a single institution experience
Gustavo A Viani, Paulo E Novaes, Alexandre A Jacinto, Celia B Antonelli, Antonio Cassio A Pellizzon, Elisa Y Saito, João V Salvajoli
Radiation Oncology 2008, 3:9 (19 April 2008)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central] [1 comment]

Research    
Expanded risk groups help determine which prostate radiotherapy sub-group may benefit from adjuvant androgen deprivation therapy
Matthew Beasley, Scott G Williams, Tom Pickles, The BCCA Prostate Outcomes Unit
Radiation Oncology 2008, 3:8 (18 April 2008)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]

register
Radiation Oncology
BioMed Central
Current Controlled
Trials
PubMed
PubMed Central




© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.